Azithromycin NDC 0781-8091

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-8091Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-8091Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0781-8091-31	00781809131	30 TABLET, FILM COATED in 1 BOTTLE (0781-8091-31)Marketed from Feb 14, 2019

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Azithromycin
Generic name (nonproprietary): azithromycin
Active ingredients: Azithromycin dihydrate — 600 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065209
Marketing start: Nov 14, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Macrolides (Chemical structure)
Identifiers: Product ID 0781-8091_2c6bb78a-a9da-43e0-9a72-b8723229e1b7SPL ID 2c6bb78a-a9da-43e0-9a72-b8723229e1b7SPL set ID 34b70c23-92a6-460f-8dbb-15a0e6b9d3a9RxCUI 204844UNII 5FD1131I7S
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400781809131 followed by a unit qualifier and the quantity

Package 00781-8091-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 30, 2026.

Indications (excerpt from the label)

Azithromycin is a macrolide antibacterial indicated for the treatment of adult patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below: • Sexually Transmitted Diseases ( 1.1 ) • Mycobacterial Infections ( 1.2 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.3 ) 1.1 Sexually Transmitted Diseases Azithromycin tablets are indicated for the treatment of adult patients with mild to mod…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)